{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:13:54Z","timestamp":1778926434414,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.breast.2026.104787","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:54:50Z","timestamp":1776146090000},"page":"104787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Phase I study of stereotactic ablative radiotherapy (SABR) in inoperable breast cancer"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5425-3471","authenticated-orcid":false,"given":"C.","family":"De la Pinta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gamero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Muriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.B.","family":"Capuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Moris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alarza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hernanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Garc\u00eda Bermejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2026.104787_bib1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/bjs.9616","article-title":"Impact of omission of surgery on survival of older patients with breast cancer","volume":"101","author":"de Glas","year":"2014","journal-title":"Br J Surg"},{"key":"10.1016\/j.breast.2026.104787_bib2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ejca.2004.12.025","article-title":"Less extensive treatment and inferior prognosis for breast cancer patient with comorbility: a population-based study","volume":"41","author":"Louwman","year":"2005","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.breast.2026.104787_bib4","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1245\/s10434-022-12133-8","article-title":"Does breast-conserving surgery with radiotherapy have a better survival than mastectomy? A meta-analysis of more than 1,500,000 patients","volume":"29","author":"De la Cruz Ku","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104787_bib5","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","article-title":"European society for radiotherapy and oncology advisory committee in radiation oncology practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer","volume":"23","author":"Meattini","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2026.104787_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejca.2012.08.010","article-title":"Omission of surgery in elderly patients with early stage breast cancer","volume":"49","author":"Hamaker","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2026.104787_bib7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bjc.6603600","article-title":"Surgery, with or without tamoxifen vs tamoxifen alone for older women with operable breast cancer: cochrane review","volume":"96","author":"Hind","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2026.104787_bib8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.4603","article-title":"Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer","volume":"91","author":"Fennessy","year":"2004","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.breast.2026.104787_bib9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.critrevonc.2013.03.007","article-title":"Design of oncology clinical trials: a review","volume":"88","author":"Ananthakrishnan","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.breast.2026.104787_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0360-3016(03)00589-3","article-title":"Cosmesis from the patient's and the doctor's view","volume":"57","author":"Hoeller","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2026.104787_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","article-title":"Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.breast.2026.104787_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK standardisation of breast radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"9","author":"Bentzen","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2026.104787_bib13","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-Year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2026.104787_bib14","series-title":"Basic clinical radiobiology","first-page":"134","article-title":"The linear-quadratic model in clinical practice","author":"Bentzen","year":"2002"},{"issue":"2","key":"10.1016\/j.breast.2026.104787_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10549-022-06802-1","article-title":"Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis","volume":"197","author":"Glynn","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.breast.2026.104787_bib16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijrobp.2022.12.028","article-title":"Cost-effectiveness analysis of ultra-hypofractionated whole breast radiation therapy alone versus hormone therapy alone or combined treatment for low-risk ER-Positive early stage breast cancer in women aged 65 years and older","volume":"116","author":"Ward","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.breast.2026.104787_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-102952","article-title":"Neoadjuvant stereotactic body radiotherapy combined with chemotherapy and Ivonescimab for Chinese luminal-type breast cancer patients: study protocol for a single-arm, open-label, phase II trial","volume":"15","author":"Zhang","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.breast.2026.104787_bib18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.101583.3","article-title":"Efficacy and safety of neoadjuvant stereotactic body radiation therapy plus dalpiciclib and exemestane for hormone receptor-positive, HER2-negative breast cancer: a prospective pilot study","volume":"14","author":"Zhang","year":"2025","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.breast.2026.104787_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13014-024-02497-4","article-title":"Advances in breast cancer treatment: a systematic review of preoperative stereotactic body radiotherapy (SBRT) for breast cancer","volume":"19","author":"Bilski","year":"2024","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104787_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2019.02.047","article-title":"Biological principles of stereotactic body radiation therapy (SBRT) and stereotactic radiation surgery (SRS): indirect cell death","volume":"110","author":"Song","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2026.104787_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251387534","article-title":"Molecular mechanisms underlying the abscopal effect induced by radiotherapy and its synergistic translational potential with immunotherapy","volume":"17","author":"Chen","year":"2025","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.breast.2026.104787_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818799355","article-title":"Definitive radiotherapy with SBRT or IMRT boost for breast cancer: excellent local control and cosmetic outcome","volume":"17","author":"Shibamoto","year":"2018","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.breast.2026.104787_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.prro.2023.12.003","article-title":"Locoregional ablative radiation therapy for patients with breast cancer unsuitable for surgical resection","volume":"14","author":"Moore-Palhares","year":"2024","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104787_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.advms.2024.01.002","article-title":"Stereotactic body radiation therapy (SBRT) for the treatment of primary breast cancer in patients not undergoing surgery","volume":"69","author":"Zabrocka","year":"2024","journal-title":"Adv Med Sci"},{"issue":"6","key":"10.1016\/j.breast.2026.104787_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.prro.2018.03.006","article-title":"Durable response of early-stage breast cancer to bilateral definitive SBRT in a medically inoperable patient","volume":"8","author":"Gao","year":"2018","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"10.1016\/j.breast.2026.104787_bib26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.rpor.2020.06.011","article-title":"Definitive single fraction stereotactic ablative radiotherapy for inoperable early-stage breast cancer: a case report","volume":"25","author":"Veluvolu","year":"2020","journal-title":"Rep Practical Oncol Radiother"},{"issue":"17","key":"10.1016\/j.breast.2026.104787_bib27","doi-asserted-by":"crossref","first-page":"15553","DOI":"10.1007\/s00432-023-05053-x","article-title":"Definitive ablative stereotactic partial breast irradiation in early stage inoperable breast cancer","volume":"149","author":"Miljanic","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2026.104787_bib28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijrobp.2023.08.064","article-title":"Utility of stereotactic body radiation therapy in establishing local control for patients with invasive breast cancer not undergoing definitive surgery","volume":"118","author":"Zabrocka","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.breast.2026.104787_bib29","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.ijrobp.2009.01.009","article-title":"Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation","volume":"75","author":"Hepel","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.breast.2026.104787_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2009.01.041","article-title":"Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation","volume":"76","author":"Jagsi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626000974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626000974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:59:24Z","timestamp":1778925564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977626000974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"alternative-id":["S0960977626000974"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2026.104787","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase I study of stereotactic ablative radiotherapy (SABR) in inoperable breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2026.104787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104787"}}